Europe

Mar 16, 2018
James Burt, Accord Healthcare’s EVP, Europe and MENA, outlines his optimistic vision for the UK and Europe post-Brexit and the challenges of retaining a company culture amid major growth.
Feb 20, 2018
In the coming weeks, the EU will decide if the degree of protection offered to drug firms by research incentives such as the SPC are really in the interests of patients and society. Reflector reports.
Feb 06, 2018
Pharmaceutical Executive
Julian Upton assembles a few rare slivers of positivity on UK pharma's future.
Jan 30, 2018
As the Ukranian healthcare market opens up to more public and private competition, it will become more attractive for investors — both Ukrainian and foreign, write Lana Sinichkina and Anna Zorya.
Jan 24, 2018
Reflector reports on the EU's legislative move to push the fifty or so national and regional HTA organizations in Europe towards greater cooperation.
Dec 10, 2017
Pharmaceutical Executive
New action plan urges tighter alignment of public health policy with the development of targeted therapies.
Nov 17, 2017
Allergan's CEO Brent Saunders explains why the European Medicines Agency should choose Dublin as its headquarters after leaving London.
Oct 10, 2017
Pharmaceutical Executive
European Commission talks drug industry investment, health issues during State of the Union.
Oct 06, 2017
The UK's Association of the British Pharmaceutical Industry had hoped to stop a new policy that amounts to price negotiation and potentially delaying access to new medicines.
Sep 28, 2017
Leela Barham looks at the reasons behind the Association of the British Pharmaceutical Industry's bid to legally challenge NICE's proposed introduction of the budget impact test.
native1_300x100
lorem ipsum